医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

HISA and Vocera to Co-host Webinar Addressing Cognitive Overload Among Clinicians

2019年10月03日 AM07:04
このエントリーをはてなブックマークに追加


 

SAN JOSE, Calif.

Vocera Communications, Inc. (NYSE:VCRA), a recognised leader in clinical communication and workflow solutions, today announced that it is co-hosting a webinar with Health Informatics Society of Australia (HISA) on strategies to reduce clinician cognitive overload and improve patient safety. The complimentary webinar, led by Vocera Chief Nursing Officer Rhonda Collins, DNP, RN, is on Wednesday, Oct. 9 at 12 p.m. AEDT.

Dr. Collins will discuss signs of cognitive overload, identify behaviors that put patient care at risk, and outline a strategy to mitigate administrative and cognitive burdens among clinicians. A nurse for more than 30 years, she understands the importance of creating an ideal working environment that fosters care team well-being and retention.

“A combination of stress, fatigue, interruptions, incessant alerts and alarms, shifting priorities, and more can all lead to cognitive overload, which can lead to mistakes,” Dr. Collins said. “It is critical for healthcare leaders to proactively find solutions that simplify clinical workflows and make the lives of nurses, physicians and care team members easier. Doing so will help improve patient care, safety and experience.”

Click here to register for the HISA webinar on Oct. 9; and join Dr. Collins for this important and interactive discussion.

About HISA

The Health Informatics Society of Australia (HISA) is a not for profit company limited by guarantee that provides leadership, advocacy and support for Australia’s digital health community. As the peak professional body, it provides a national focus for digital health and health informatics, and opportunities for learning, professional development and networking to the diverse and growing community at the intersection of healthcare and technology. HISA provides members and stakeholders with a national, state and local events program, a national network of state branches, communities of practice, a professional certification, links to an international network and opportunities to contribute to the development of national standards, professional practice guidelines and position papers.

About Vocera

The mission of Vocera Communications, Inc. is to simplify and improve the lives of healthcare professionals and patients, while enabling hospitals to enhance quality of care and operational efficiency. In 2000, when the company was founded, we began to forever change the way care teams communicate. Today, Vocera offers the leading platform for improving clinical communication and workflow. More than 1,850 facilities worldwide, including nearly 1,600 hospitals and healthcare facilities, have selected our clinical communication and workflow solutions. Care team members use our solutions to communicate and collaborate with co-workers by securely texting or calling, and to be notified of important alerts and alarms. They can choose the right device for their role or task, including smartphones or our hands-free, wearable Vocera Smartbadge and Vocera Badge. Interoperability between the Vocera Platform and more than 140 clinical and operational systems helps reduce alarm fatigue; speed up staff response times; and improve patient care, safety, and experience. In addition to healthcare, Vocera is at home in luxury hotels, aged care facilities, nuclear power facilities, schools, libraries, retail stores, and more. Vocera solutions make a difference in any industry where workers are on the move and need to connect instantly with team members and access resources or information quickly. In 2017, Vocera made the list of Forbes 100 Most Trustworthy Companies.

Vocera® and the Vocera logo are trademarks of Vocera Communications, Inc. registered in the United States and other jurisdictions. All other trademarks appearing in this release are the property of their respective owners.

View source version on businesswire.com: https://www.businesswire.com/news/home/20191002005308/en/

CONTACT

John Elias

Vocera Communications, Inc

+1 416 899-4976

jelias@vocera.com

同じカテゴリーの記事 

  • La Jolla Institute for Immunology and RevolKa started a Research Collaboration
  • U.S. FDA Approves Subcutaneous Administration of Takeda’s ENTYVIO® (vedolizumab) for Maintenance Therapy in Moderately to Severely Active Crohn’s Disease
  • ESCMID Global 2024: Shionogi presents real-world data demonstrating efficacy of Fetcroja® / Fetroja® (cefiderocol) in critically ill patients with certain difficult-to-treat bacterial infections
  • Renesas’ New FemtoClock™ 3 Timing Solution Delivers Industry’s Lowest Power and Leading Jitter Performance of 25fs-rms
  • 成人向け予防接種プログラムは初期投資の19倍もの社会経済的価値をもたらすとの新レポートを発表